Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS1 | P29475 | 10/20 | 1.00 |
| ▸ | NOS2 | P35228 | 9/20 | 1.00 |
| ▸ | NOS3 | P29474 | 6/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.71 |
| ▸ | THPO | P40225 | 1/20 | 0.71 |
| ▸ | DDAH1 | O94760 | 5/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.63 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.62 |
| ▸ | TSHR | P16473 | 2/20 | 0.62 |
| ▸ | GLA | P06280 | 1/20 | 0.62 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.62 |
| ▸ | APEX1 | P27695 | 1/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | BLM | P54132 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9115754 | 0.88 | NOS1 (0.78) | NOS1NOS2NOS3CYP2C19THPO | |
| SCHEMBL9141669 | 0.86 | NOS1 (0.76) | NOS1NOS2NOS3CYP2C19THPO | |
| SCHEMBL29941582 | 0.85 | NOS1 (0.74) | NOS1NOS2NOS3CYP2C19THPO | |
| SCHEMBL9113062 | 0.85 | NOS1 (0.74) | NOS1NOS2NOS3CYP2C19THPO | |
| SCHEMBL9114350 | 0.84 | NOS1 (0.73) | NOS1NOS2NOS3CYP2C19THPO | |
| S-Methyl-D-Thiocitrulline SCHEMBL9114394 | 0.83 | NOS1 (1.00) | NOS1NOS2NOS3CYP2C19THPO | |
| Thiocitrulline SCHEMBL940520 | 0.83 | NOS1 (1.00) | NOS1NOS2NOS3CYP2C19THPO | |
| SCHEMBL9141622 | 0.83 | NOS2 (0.71) | NOS1NOS2NOS3CYP2C19THPO | |
| Thiocitrulline SCHEMBL4406617 | 0.82 | NOS1 (0.97) | NOS1NOS2NOS3CYP2C19THPO | |
| Thiocitrulline SCHEMBL1320099 | 0.81 | NOS2 (0.94) | NOS1NOS2NOS3CYP2C19THPO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 355 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10556005-B2 | Adjuvant composition containing citrulline | THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE (JP) | 2020-02-11 | — | — | US | claimed |
| US-20170239348-A1 | ADJUVANT COMPOSITION CONTAINING CITRULLINE | THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE (JP) | 2017-08-24 | — | — | US | claimed |
| US-9381242-B2 | Adjuvant composition containing citrulline | THE CHEMO—SERO—THERAPEUTIC RESEARCH INSTITUTE (JP) | 2016-07-05 | — | — | US | claimed |
| CN-103561764-B | adjuvant composition containing citrulline | THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE (JP) | 2015-09-16 | — | — | CN | claimed |
| US-20140065179-A1 | ADJUVANT COMPOSITION CONTAINING CITRULLINE | THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE (JP) | 2014-03-06 | — | — | US | claimed |
| CN-103561764-A | Adjuvant composition containing citrulline | CHEMO SERO THERAPEUT RES INST | 2014-02-05 | — | — | CN | claimed |
| EP-2684572-A1 | ADJUVANT COMPOSITION CONTAINING CITRULLINE | The Chemo-Sero-Therapeutic Research Institute (JP) | 2014-01-15 | — | — | EP | claimed |
| US-20100158857-A1 | Compositions and methods for the inhibition of endothelial nitric oxide synthase activity | UNIVERSITY OF UTAH RESEARCH FOUNDATION | 2010-06-24 | — | — | US | claimed |
| EP-2020998-A1 | COMPOSITIONS AND METHODS FOR THE INHIBITION OF ENDOTHELIAL NITRIC OXIDE SYNTHASE ACTIVITY | University of Utah Research Foundation (US) | 2009-02-11 | — | — | EP | claimed |
| WO-2007139897-A1 | COMPOSITIONS AND METHODS FOR THE INHIBITION OF ENDOTHELIAL NITRIC OXIDE SYNTHASE ACTIVITY | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2007-12-06 | — | — | WO | claimed |
| US-6656925-B2 | Composition and method of treating arthritis | ADVANCED MEDICAL INSTRUMENTS | 2003-12-02 | — | — | US | claimed |
| JP-2002541077-A | — | — | 2002-12-03 | — | — | JP | claimed |
| US-20020119952-A1 | Composition and method of treating arthritis | ADVANCED MEDICAL INSTRUMENTS | 2002-08-29 | — | — | US | claimed |
| EP-1233786-A2 | PRODUCT COMPRISING AT LEAST A NO SYNTHASE INHIBITING SUBSTANCE ASSOCIATED WITH AT LEAST A PHOSPHOLIPASE A2 INHIBITING SUBSTANCE | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) | 2002-08-28 | — | — | EP | claimed |
| EP-1169005-A2 | ASSOCIATION OF NO-SYNTHASE INHIBITOR(S) AND METABOLIC ANTIOXIDANT(S) | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) | 2002-01-09 | — | — | EP | claimed |
| WO-2001032216-A2 | PRODUCT COMPRISING AT LEAST A NO SYNTHASE INHIBITING SUBSTANCE ASSOCIATED WITH AT LEAST A PHOSPHOLIPASE A2 INHIBITING SUBSTANCE | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) | 2001-05-10 | — | — | WO | claimed |
| WO-2000059448-A2 | ASSOCIATION OF NO-SYNTHASE INHIBITOR(S) AND METABOLIC ANTIOXIDANT(S) | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) | 2000-10-12 | — | — | WO | claimed |
| US-6043268-A | Agent for treatment of viral infections | Maeda, Hiroshi (JP) | 2000-03-28 | — | — | US | claimed |
| EP-0939654-A1 | ASSOCIATION OF NO SYNTASE INHIBITORS WITH TRAPPERS OF OXYGEN REACTIVE FORMS | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) | 1999-09-08 | — | — | EP | claimed |
| WO-1998009653-A1 | ASSOCIATION OF NO SYNTASE INHIBITORS WITH TRAPPERS OF OXYGEN REACTIVE FORMS | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) | 1998-03-12 | — | — | WO | claimed |